Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Baxter
McKesson
Deloitte
AstraZeneca
Johnson and Johnson
Chinese Patent Office
QuintilesIMS
McKinsey
Julphar

Generated: October 18, 2017

DrugPatentWatch Database Preview

HYTONE Drug Profile

« Back to Dashboard

Which patents cover Hytone, and when can generic versions of Hytone launch?

Hytone is a drug marketed by Valeant Intl and Dermik Labs and is included in three NDAs.

The generic ingredient in HYTONE is hydrocortisone. There are sixty drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.

Summary for Tradename: HYTONE

US Patents:0
Applicants:2
NDAs:3
Bulk Api Vendors: see list56
Clinical Trials: see list4
Patent Applications: see list9,814
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYTONE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Intl
HYTONE
hydrocortisone
CREAM;TOPICAL080472-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Intl
HYTONE
hydrocortisone
LOTION;TOPICAL080473-004Nov 30, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Intl
HYTONE
hydrocortisone
CREAM;TOPICAL080472-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Intl
HYTONE
hydrocortisone
LOTION;TOPICAL080473-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dermik Labs
HYTONE
hydrocortisone
OINTMENT;TOPICAL080474-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dermik Labs
HYTONE
hydrocortisone
OINTMENT;TOPICAL080474-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Dow
Colorcon
Citi
Mallinckrodt
Harvard Business School
Cipla
Express Scripts
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot